Aspirin for the treatment of venous leg ulcers is an inexpensive, widely used medication but its safety and efficacy was unknown. Our pilot study found there was no evidence that aspirin was efficacious in hastening the healing of chronic venous leg ulcers and an effectiveness trial would not be feasible.
Venous leg ulcers can take many months to heal and 25% fail to heal. The main treatment for venous leg ulcers is compression therapy and few other therapies exist. Two previous trials indicated that low-dose aspirin may improve healing time, but these trials were insufficiently robust.
We carried out a multi-centred, pilot, phase II, randomised, double blind, parallel-group, placebo-controlled, efficacy trial (RCT) to determine: if aspirin improves venous leg ulcer healing time; the safety of aspirin in this population; treatment compliance; and the feasibility of recruitment to a full trial. Participants were randomly assigned to receive 300 mg of daily aspirin or placebo in addition to standard care, which consisted of multi component compression therapy aiming to deliver 40 mmHg at the ankle where possible. The primary outcome was time to ulcer healing.
We recruited patients from secondary care who were aged 18 years or above, had a chronic venous leg ulcers and not regularly taking aspirin.
We were unable to recruit to target despite exploring options: a short time-frame to recruit and failure to meet the eligibility criteria were the main barriers to recruitment. There was no evidence that aspirin was effective in expediting the healing of chronic venous leg ulcer. However, the analysis was underpowered due to the low number of participants recruited. The study design would require substantial amendment in order to progress to a full effectiveness trial.
Department of Health Sciences, University of York, York, UK
St George’s Vascular Institute, St George’s Healthcare NHS Trust, London, UK
St George’s University of London, London, UK
Hull York Medical School, University of Hull, Kingston upon Hull, UK
School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK
Wound Healing Research Unit, Cardiff University, Cardiff, UK
Harrogate and District NHS Foundation Trust, London, UK
The Lindsay Leg Club Foundation, London, UK
School of Health Sciences, University of Nottingham, Nottingham, UK
Swansea Centre for Health Economics, Swansea University, Swansea, UK
School of Surgical and Reproductive Sciences, Newcastle University, Newcastle upon Tyne, UK
University of Bradford, Bradford, UK
The research was commissioned by NIHR HTA programme (Award ID: 13/87/08) and a grant of £293,432.35 awarded. The project was started in January 2015 and completed in November 2016.
The study is registered on a public database with clinicaltrials.gov (NCT02333123; registered on 5 November 2014).